Jefferies analyst Roger Song set a $150 price target for Nektar Therapeutics, suggesting a 219% upside from its $46.99 trading price. This comes after Nektar presented positive six-month Phase IIb trial results for its alopecia drug REZPEG, which also targets atopic dermatitis and Type 1 diabetes. Despite the promising data showing maintained hair regrowth post-treatment, Nektar's stock fell 22.39% on the day of the announcement. The company plans a Phase III study with a selected dose of 24 micrograms per kilogram every two weeks, aiming to advance the drug's development further.
Nektar Therapeutics stock is the subject here, with no direct Pluang data available. For readers following the health sector, here is Pluang's market snapshot as of Oct 02, 2026 03:12 WIB: out of 100 health-sector US stocks, 13 rose and 86 fell. Notable movers include AMWL at USD 12.79 with a -5.82% change, ADPT at USD 27.27 with a -5.66% change and 100% buy order activity, and BIO at USD 356.57 with a -5.60% change.
Wells Fargo initiated coverage on BlackRock with an 'Overweight' rating, highlighting it as a good entry point for investors. Analysts expect BlackRock's Q3 earnings per share to rise to $14.25 from $11.55 a year ago, with revenue projected at $7.56 ...
Nike reported earnings per share of $0.48, beating estimates, but revenue fell short at $11.21 billion due to weak demand in Greater China and rising competition. The company issued a cautious fiscal 2027 outlook with EPS forecast between $1.15 and $...
NETSOL Technologies reported a record $20.7 million revenue in fiscal 2026 Q4, with net income rising 45.9% to $3.8 million. The company improved its gross margin to 63.6% and operating margin to 21.6%, reflecting enhanced profitability. For fiscal 2...
On October 1, 2026, Nexalin Technology surged 76.4% after securing a 10-year exclusive deal for its medical device in South America. Armada Acquisition Corp. II jumped 42.9% following shareholder approval of its merger with Evernorth, expected to clo...
Boeing's stock rose following the approval of a new four-year union contract covering 13,000 engineers and 4,000 technical workers. The agreement prevents a potential strike that could have disrupted 737 production and delayed aircraft deliveries, pr...
